Related Experiment Video

Updated: Jul 26, 2025

Quantifying the Effects of Antimicrobials on In vitro Biofilm Architecture using COMSTAT Software
06:18

Quantifying the Effects of Antimicrobials on In vitro Biofilm Architecture using COMSTAT Software

Published on: December 14, 2020

3.4K

Antibiotic treatment duration for community-acquired pneumonia in children

Shalini Singla, Kendra Sih, Ran D Goldman

    Canadian Family Physician Medecin De Famille Canadien
    |June 14, 2023
    PubMed

    Insights

    For uncomplicated community-acquired pneumonia (CAP) in children treated outpatient, a shorter antibiotic course of 3 to 5 days is as effective as longer durations. This approach helps minimize antimicrobial resistance risks.

    Area of Science:

    • Pediatric infectious diseases
    • Antimicrobial stewardship

    Background:

    • Community-acquired pneumonia (CAP) is a common childhood illness.
    • Historically, 10-day antibiotic courses were standard for CAP treatment.

    Purpose of the Study:

    • To evaluate the current evidence for optimal antibiotic treatment duration in uncomplicated pediatric CAP.
    • To inform clinical practice regarding antibiotic prescribing for CAP.

    Main Methods:

    • Review of recent randomized controlled trials (RCTs).
    • Analysis of evidence comparing shorter (3-5 days) versus longer antibiotic durations.

    Main Results:

    • Evidence suggests 3- to 5-day antibiotic courses are non-inferior to longer durations for uncomplicated CAP.
    • Shorter courses reduce antibiotic exposure.

    Conclusions:

    • Prescribing 3- to 5-day antibiotic courses for uncomplicated pediatric CAP is recommended.
    • This practice supports antimicrobial stewardship and reduces resistance risk.
    Abstract

    More Related Videos

    Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung09:26

    Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung

    Published on: January 22, 2021

    7.0K
    A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii09:17

    A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

    Published on: January 2, 2017

    14.8K

    Related Concept Videos

    Pneumonia IV: Management01:28

    Pneumonia IV: Management

    The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
    Bacterial Pneumonia Treatment
    For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
    399
    Acute Pyelonephritis II: Diagnostic Studies and Management01:28

    Acute Pyelonephritis II: Diagnostic Studies and Management

    Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
    19
    Pulmonary Tuberculosis V01:28

    Pulmonary Tuberculosis V

    Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
    Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
    214
    Pneumonia I: Introduction01:30

    Pneumonia I: Introduction

    Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
    Risk Factors
    Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
    285
    Pneumonia V: Nursing management and Prevention01:30

    Pneumonia V: Nursing management and Prevention

    Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
    The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
    Enhance airway patency
    Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
    2.2K
    Tonsillitis II: Management01:26

    Tonsillitis II: Management

    This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
    145